How to buy Chimerix stock

Chimerix, Inc is a biotechnology business based in the US. Chimerix shares (CMRX) are listed on the NASDAQ and all prices are listed in US Dollars. Chimerix employs 54 staff and has a trailing 12-month revenue of around USD$5.4 million.

How to buy shares in Chimerix

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Chimerix. Find the stock by name or ticker symbol: CMRX. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Chimerix reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Chimerix, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Chimerix. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced investors

Webull

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active investors. We picked Webull for this category because its platform offers features that cater to advancing investors as well as beginners. The desktop app is outfitted with an extensive set of research tools, the mobile app gets high grades from users and traders can test strategies with a paper-trading feature.

What's in this guide?

1. CMRX shares summary
2. Compare share dealing platforms
3. Is CMRX stock a buy or sell?
4. Stock performance over time
5. Can I short CMRX shares?
6. Chimerix's financials
7. How volatile are CMRX shares?
8. Does Chimerix pay a dividend?
9. Other common questions

Chimerix share price

Use our graph to track the performance of CMRX stocks over time.

Chimerix shares at a glance

• Key figures

Information last updated 2021-03-03.

52-week range	USD$1.19 - USD$11.57
50-day moving average	USD$9.4976
200-day moving average	USD$4.9444
Wall St. target price	USD$13.33
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-1.321

Buy Chimerix shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Webull		$0	Stocks, Options, ETFs	$0	0%	Get two free stock valued between $2.50 and $250 Open an account	Margin financing rates start at 3.99%. No monthly subscription fees for margin.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Chimerix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Chimerix, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Chimerix shares

There are currently 794,294 Chimerix shares held short by investors – that's known as Chimerix's "short interest". This figure is 15% down from 933,964 last month.

There are a few different ways that this level of interest in shorting Chimerix shares can be evaluated.

Chimerix's "short interest ratio" (SIR)

Chimerix's "short interest ratio" (SIR) is the quantity of Chimerix shares currently shorted divided by the average quantity of Chimerix shares traded daily (recently around 1.1 million). Chimerix's SIR currently stands at 0.75. In other words for every 100,000 Chimerix shares traded daily on the market, roughly 750 shares are currently held short.

However Chimerix's short interest can also be evaluated against the total number of Chimerix shares, or, against the total number of tradable Chimerix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Chimerix's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Chimerix shares in existence, roughly 10 shares are currently held short) or 0.0138% of the tradable shares (for every 100,000 tradable Chimerix shares, roughly 14 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Chimerix.

Find out more about how you can short Chimerix stock.

Chimerix share price volatility

Over the last 12 months, Chimerix's shares have ranged in value from as little as $1.19 up to $11.57. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Chimerix's is 1.6462. This would suggest that Chimerix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Chimerix overview

Chimerix, Inc., a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include dociparstat sodium (DSTAT), a potential first-in-class glycosaminoglycan compound derived from porcine heparin that has low anticoagulant activity but retains the ability to inhibit activities of key proteins implicated in the retention and viability of acute myeloid leukemia blasts and leukemic stem cells in the bone marrow during chemotherapy; and brincidofovir (BCV), an antiviral drug candidate in development as a medical countermeasure for smallpox. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications; and University of Michigan to research, develop, manufacture, and commercialize various products. Chimerix, Inc. was founded in 2000 and is headquartered in Durham, North Carolina.

Frequently asked questions

• What percentage of Chimerix is owned by insiders or institutions?

  Currently 18.335% of Chimerix shares are held by insiders and 53.067% by institutions.

• How many people work for Chimerix?

  Latest data suggests 54 work at Chimerix.

• When does the fiscal year end for Chimerix?

  Chimerix's fiscal year ends in December.

• Where is Chimerix based?

  Chimerix's address is: 2505 Meridian Parkway, Durham, NC, United States, 27713

• What is Chimerix's ISIN number?

  Chimerix's international securities identification number is: US29664W1053

• What is Chimerix's CUSIP number?

  Chimerix's Committee on Uniform Securities Identification Procedures number is: 16934W106